TriRx Pharmaceutical Services is a contract development and manufacturing organization (CDMO) that provides pharmaceutical manufacturing, packaging, and laboratory services. Founded in 2019, the company operates facilities in multiple locations, including Huntsville, Alabama, USA, and Segrate, Italy. The company specializes in the production of both sterile and non-sterile pharmaceutical products, offering services across various dosage forms including oral solids, liquids, and sterile injectables. TriRx acquired its Huntsville facility from Merck & Co. in 2020 and its Segrate facility from Pfizer in 2021, expanding its global manufacturing capabilities. TriRx provides end-to-end solutions for pharmaceutical companies, including process development, analytical testing, clinical trial material manufacturing, commercial manufacturing, and packaging services. The company serves both large pharmaceutical companies and emerging biotech firms, supporting them throughout their products’ lifecycle from development to commercial production. The organization maintains compliance with current Good Manufacturing Practice (cGMP) standards and holds necessary regulatory certifications from authorities including the FDA and EMA. TriRx’s business model focuses on acquiring and operating established pharmaceutical manufacturing facilities while maintaining quality standards and supporting local employment in the communities where they operate.